Robotic extended re-thymectomy for refractory myasthenia gravis: a case series
To assess the safety and efficacy of robotic extended re-thymectomy in selected refractory myasthenia gravis (MG) patients with suspected residual thymic tissue. Robotic extended re-thymectomy was performed in six MG patients with seropositive acetylcholine receptors (AChR) antibody who had undergone a previous thymectomy (one cervicotomy, two video-assisted thoracoscopic surgeries and three sternotomies). The median observation time before robotic re-thymectomy was 108 (24-171) months. The main outcomes were perioperative morbidity, mortality, conversion to open surgery and clinical outcomes according to the Myasthenia Gravis Foundation of America Post-Intervention Status (MGFA-PIS).
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Feng Li, Zhongmin Li, Reona Takahashi, Anagnostopoulos Ioannis, Mahmoud Ismail, Andreas Meisel, Jens-C. Rueckert Tags: THORACIC – Original Submission Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Myasthenia Gravis